Concepedia

Chris Karlovich

CK

32

Publications

4.9K

Citations

25

H-Index

1991

Active since

Affiliations

Frederick National Laboratory for Cancer Research(Current)

Massachusetts General Hospital

Stanford University

University of Colorado Denver

University of California, Los Angeles

Chris Karlovich is an author at Frederick National Laboratory for Cancer Research specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1991–2022

32

Publications

32

Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer

Lecia V. Sequist, Jean‐Charles Soria, Jonathan W. Goldman et al. · New England Journal of Medicine · 2015 · 660 citations · Full text

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

Jacob J. Chabon, Andrew D. Simmons, Alexander F. Lovejoy et al. · Nature Communications · 2016 · 650 citations · Full text

, , +15

TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository

Yingdong Zhao, Ming‐Chung Li, Mariam M. Konaté et al. · Journal of Translational Medicine · 2021 · 488 citations · Full text

Heterogeneity Underlies the Emergence of <i>EGFR</i> T790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor

Zofia Piotrowska, Matthew J. Niederst, Chris Karlovich et al. · Cancer Discovery · 2015 · 453 citations · Full text

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

Karen L. Reckamp, Vladislava O. Melnikova, Chris Karlovich et al. · Journal of Thoracic Oncology · 2016 · 283 citations · Full text

Rows per page

1–5 of 32